Medical technology company: Vapor Inc. (VAPO)

Vapotherm Inc.( OTCQX VAPO), founded in 1993, headquartered in Exeter, New Hampshire, USA, with 182 full-time employees, is a global medical technology company focusing on the development and commercialization of the company's proprietary Hi VNI technology products, which are used to treat patients of all ages with respiratory distress.

The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

Vaporm Inc. (VAPO)

Vaporm, Inc., a medical technology company, specializes in developing and commercializing proprietary high-speed treatment products for patients with respiratory distress of all ages in the United States and internationally. The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

Vaporm provides high-speed treatment systems, such as HVT 2.0, Precision Flow Hi VNI, Precision Flow Plus, and Precision Flow Classic, which provide high-speed heating, humidification, and oxygenated air through a small caliber nasal interface to treat patients, thus providing non-invasive ventilation support for patients. The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

Vaporm also provides supporting products, including Vaporm Transfer Unit, which allows patients to transfer between different nursing areas in the hospital or walk when receiving treatment; Q50 compressor, which provides the compressed air needed to run the precision flow system in the area where the wall air source cannot be used in the hospital; Aerosol aeroneb adapter is used for convenient transportation of atomized solution; The disposable patient circuit of aerosol is designed to simplify the process of providing continuous and intermittent aerosol solution for patients; The tracheotomy adapter simplifies the connection between the high-speed treatment system and the tracheotomy collar, and is used to make the patient out of mechanical ventilation. The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

In addition, Vaporm also provides ProSoft sleeves for gentle contact with skin; As well as disposable products, including disposable supplies and nasal interfaces, as well as oxygen assist module, to help clinicians maintain oxygen levels within the target range. The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

Respiratory distress is caused by a variety of serious underlying diseases, including pneumonia, chronic obstructive pulmonary disease (COPD), asthma and heart failure. Patients with respiratory distress have severe breathing difficulties, unable to maintain adequate oxygen levels or eliminate residual carbon dioxide in the lungs and airways. These patients need immediate respiratory support, from supplemental oxygen therapy in mild cases to invasive mechanical respiration in severe cases. The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

A series of striking clinical data support the efficacy and benefits of Hi VNI technology on respiratory distress. U.S.A food And the Drug Administration (FDA) recently approved the updated version of Precision Flow System being developed by Vaporm. FDA has also formulated a new classification regulation, according to which the updated version of Vaporm's Precision Flow system is the only product currently listed. This FDA instruction established Hi VNI technology as an attractive alternative to the existing nursing standards for the treatment of respiratory distress and non-invasive positive pressure ventilation (NIPPV). The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

Vaporm sells Precision Flow system to hospitals through direct sales organizations in the United States and distributors in specific countries outside the United States. Doctors, respiratory therapists and nurses who specialize in working in emergency hospital environments, including emergency department (ED), and adult, pediatric and neonatal intensive care unit (ICU) customers. The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

Historical Encyclopedia of Vaporm Inc. (VAPO)

In November 2015, Vaporm announced the launch of its own medical air compressor model Q50 Compressor, which is specially used for its flagship product Precision Flow equipment. The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

As of September 30, 2018, more than 1.5 million patients have received the treatment of Vaporm, Inc.'s precision flow system, and the company has more than 12000 installation points. The article originates from American Stock House | American Stock Encyclopedia | Hong Kong and US Stock Account Opening Investment- https://www.mg21.com/vapo.html

November 14, 2018, Vapor Inc. (NYSE: VAPO) IPO Landing on NYSE, offering price is $14.00, issuing 4 million shares, raising $56 million, BofA Merrill Lynch/ William Blair Underwriting.

On June 17, 2024, Vaporm (OTCQX: VAPO) signed a merger agreement with a newly established entity, which is a healthcare investment company Perceptive Advisors Its subsidiaries and its Perceptual Discovery Fund.

Vaporm Inc. (VAPO) US equity investment